drugset / Trial / NCT00979056

Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin

NCT00979056

Phase 3 Completed 258 enrolled University Hospital Tuebingen
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of the study is to investigate the efficacy of the prophylactic treatment with rifaximin to prevent travellers diarrhoea.

Timeline

Start
2009-10
Primary completion
2012-03
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Rifaximin Other / unclassified 400 mg Oral

Indications